Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
medicare
5
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
healthcare
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
column
drug prices
health
health insurance
medicaid
negotiation
pharmacy benefit managers
pricing
senate
abbvie
adalimumab
What
lower
5
×
drug
prices
awaited
cost
details
healthcare
house
long
medicare
opportunity
patients
payment
plan
providers
services
achieving
act
administration
adopt
affordable
afternoon
align
alternative
anathema
anticipated
apms
away
better
blueprint
bringing
bundled
ceos
companies
costs
cut
dc
democrat
dollar
drives
Language
unset
Current search:
medicare
×
lower
×
@xconomy.com
4 years ago
After First Look at House Drug Plan, Stocks Rise Slightly
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away
@xconomy.com
5 years ago
Trump Pledges Lower Drug Prices, But Blueprint Is Short on Details
@techcrunch.com
8 years ago
Fee-For-Value Drives Trillion-Dollar Healthcare Opportunity
@techcrunch.com
8 years ago
Risk And Reward: The Bundled Payment Opportunity For Tech Startups